{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "SNCA",
                "Protein_Change": {
                    "ref": "A",
                    "alt": "P",
                    "position": "30"
                },
                "variant_string_id": "SNCA A30P"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Alpha - Synuclein (α - syn) is associated with presynaptic membranes in the brain and is a major constituent of Lewy bodies in Parkinson's disease (PD). The regulation of α - syn's cellular localization in neurons and the effects of PD - linked mutations are being studied.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states the association of α - syn with PD and the focus on understanding the effects of PD - linked mutations, which implies a defined disease mechanism related to α - syn's function in neurons.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "An in vitro assay was developed to characterize the factors involved in α - syn's binding to synaptic membranes. This assay measured the binding of recombinant human α - syn to synaptic membranes from α - syn - deficient mice in the presence or absence of brain cytosol.",
                    "judgment": "Yes",
                    "reasoning": "The in vitro assay to study α - syn binding to synaptic membranes is relevant to understanding the disease mechanism as α - syn's membrane binding is likely related to its role in PD pathogenesis.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "Statistical comparisons were calculated with GraphPad InStat software using Student's T - test for comparisons between two groups or ANOVA (Bonferroni test) for multiple comparisons. However, there is no clear mention of using both normal/negative/wild - type AND abnormal/positive/null controls and explicit statement of multiple replicates.",
                    "judgment": "No",
                    "reasoning": "Although statistical tests were used, the paper does not clearly state the use of both types of controls and multiple replicates.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "The methods used for synaptosome preparation, cytosol preparation, and the α - syn binding assay seem to be standard procedures in the field, but there is no clear citation of prior validation or mention of a commercial kit.",
                    "judgment": "Yes",
                    "reasoning": "The described methods are likely standard in the field, indicating that the assay is broadly accepted historically.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The functional evidence for the SNCA A30P variant is considered PS3_supporting. The disease mechanism related to α - syn in PD was defined, and the in vitro assay was applicable. However, basic controls and replicates were not clearly demonstrated. Since the assay methods are likely standard in the field, the maximum strength of PS3_supporting was assigned."
        },
        {
            "variant_id": {
                "Gene": "SNCA",
                "Protein_Change": {
                    "ref": "A",
                    "alt": "T",
                    "position": "53"
                },
                "variant_string_id": "SNCA A53T"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Alpha - Synuclein (α - syn) is associated with presynaptic membranes in the brain and is a major constituent of Lewy bodies in Parkinson's disease (PD). The regulation of α - syn's cellular localization in neurons and the effects of PD - linked mutations are being studied.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states the association of α - syn with PD and the focus on understanding the effects of PD - linked mutations, which implies a defined disease mechanism related to α - syn's function in neurons.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "An in vitro assay was developed to characterize the factors involved in α - syn's binding to synaptic membranes. This assay measured the binding of recombinant human α - syn to synaptic membranes from α - syn - deficient mice in the presence or absence of brain cytosol.",
                    "judgment": "Yes",
                    "reasoning": "The in vitro assay to study α - syn binding to synaptic membranes is relevant to understanding the disease mechanism as α - syn's membrane binding is likely related to its role in PD pathogenesis.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "Statistical comparisons were calculated with GraphPad InStat software using Student's T - test for comparisons between two groups or ANOVA (Bonferroni test) for multiple comparisons. However, there is no clear mention of using both normal/negative/wild - type AND abnormal/positive/null controls and explicit statement of multiple replicates.",
                    "judgment": "No",
                    "reasoning": "Although statistical tests were used, the paper does not clearly state the use of both types of controls and multiple replicates.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "The methods used for synaptosome preparation, cytosol preparation, and the α - syn binding assay seem to be standard procedures in the field, but there is no clear citation of prior validation or mention of a commercial kit.",
                    "judgment": "Yes",
                    "reasoning": "The described methods are likely standard in the field, indicating that the assay is broadly accepted historically.",
                    "next_step_or_outcome": "Max PS3_supporting"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The functional evidence for the SNCA A53T variant is considered PS3_supporting. The disease mechanism related to α - syn in PD was defined, and the in vitro assay was applicable. However, basic controls and replicates were not clearly demonstrated. Since the assay methods are likely standard in the field, the maximum strength of PS3_supporting was assigned."
        },
        {
            "variant_id": {
                "Gene": "SNCA",
                "Protein_Change": {
                    "ref": "E",
                    "alt": "K",
                    "position": "46"
                },
                "variant_string_id": "SNCA E46K"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Alpha - Synuclein (α - syn) is associated with presynaptic membranes in the brain and is a major constituent of Lewy bodies in Parkinson's disease (PD). The regulation of α - syn's cellular localization in neurons and the effects of PD - linked mutations are being studied.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states the association of α - syn with PD and the focus on understanding the effects of PD - linked mutations, which implies a defined disease mechanism related to α - syn's function in neurons.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "No functional data for E46K variant was presented in the paper regarding its membrane binding or other functional assays like the ones for A30P and A53T.",
                    "judgment": "No",
                    "reasoning": "Since there is no functional data for the E46K variant, the assay cannot be evaluated for its applicability to the disease mechanism.",
                    "next_step_or_outcome": "Do not use PS3/BS3"
                }
            ],
            "final_evidence_strength": {
                "type": "N/A",
                "strength": "N/A"
            },
            "overall_conclusion": "No functional evidence was provided for the SNCA E46K variant in the paper, so no PS3/BS3 strength can be assigned."
        }
    ]
}